Peritoneal Tumor Carcinomatosis: Pharmacological Targeting with Hyaluronan-Based Bioconjugates Overcomes Therapeutic Indications of Current Drugs

Peritoneal carcinomatosis still lacks reliable therapeutic options. We aimed at testing a drug delivery strategy allowing a controlled release of cytotoxic molecules and selective targeting of tumor cells. We comparatively assessed the efficacy of a loco-regional intraperitoneal treatment in immunoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Montagner, Isabella Monia, Merlo, Anna, Zuccolotto, Gaia, Renier, Davide, Campisi, Monica, Pasut, Gianfranco, Zanovello, Paola, Rosato, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226476/
https://www.ncbi.nlm.nih.gov/pubmed/25383653
http://dx.doi.org/10.1371/journal.pone.0112240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226476/
https://www.ncbi.nlm.nih.gov/pubmed/25383653
http://dx.doi.org/10.1371/journal.pone.0112240

Ejemplares similares